Recruiting NA INTERVENTIONAL 1-arm
NCT06792786
Dynamic Changes of CtDNA to Evaluate the Efficacy of Immunoconsolidation Therapy After Radiotherapy and Chemotherapy for Esophageal Cancer
Multi-center Prospective Study of Immunoconsolidation Therapy After Chemoradiotherapy for Esophageal Cancer Based on CtDNA Dynamic Detection
Sponsor: Jinhua Municipal Central Hospital
Conditions
CtDNA Esophageal Cancer
Interventions
ctDNA detection
Updated 1 time since 2025 Last updated: Jan 20, 2025 Started: Dec 10, 2024 Primary completion: May 31, 2027 Completion: Dec 30, 2027
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
This NA trial investigates CtDNA and Esophageal Cancer and is currently actively recruiting participants. Jinhua Municipal Central Hospital leads this study, which shows 1 recorded version since 2024 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.
Status Flow
Change History
1 version recorded Recruiting — NA
[monthly]
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- Jinhua Municipal Central Hospital
- The Central Hospital of Lishui City
Data source: The Central Hospital of Lishui City
For direct contact, visit the study record on ClinicalTrials.gov .